COMMUNIQUÉS West-GlobeNewswire

Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive
26/08/2019
SAN FRANCISCO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) announced today that Thomas B. Neff, Chief Executive Officer and Chairman of the Board of Directors of FibroGen, passed away unexpectedly [...]
Golden Leaf Reports Fiscal Second Quarter 2019 Results
26/08/2019
TORONTO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis oil solutions company and dispensary operator built around recognized [...]
PreCheck Health Services Signs Additional Binding Agreement to Acquire Companies to Strengthen Its Point-of-Care Medical Screening Capabilities
26/08/2019
LD Technology manufactures and markets multiple products in the medical device screening sector, including the PC8B Medical Screening Inc. holds and owns all patents and proprietary technology of LD Technology JAS [...]
Arcturus Therapeutics To Present at Two Investor Conferences in September
26/08/2019
SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and [...]
Inspire Medical Systems, Inc. Announces Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy from Two Regional Medicare Administrators
26/08/2019
Noridian Healthcare Solutions and Palmetto GBA, collectively representing 19 states, issue draft policies initiating open public comment period MINNEAPOLIS, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc [...]
PhaseBio Announces Presentation of PB2452 Data at ESC Congress 2019
26/08/2019
MALVERN, Pa. and SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
SubioMed to be a Featured Presenter at the Medical Alley Innovation Summit in Minneapolis September 11-12, 2019
26/08/2019
Two-Day Investment and Networking Event Will Feature 40 Pre-Screened Start-Up Medical Technology Companies Delivering 10-Minute Presentations MINNEAPOLIS, Aug. 26, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or [...]
Maple Leaf Green World Inc. Enters into Letter of Intent to Acquire Land, Assets and Business of Woodmere Nursery Ltd.
26/08/2019
CALGARY, Alberta, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces the following: Maple Leaf Green World is pleased to announce that [...]
BiotricityReports Fiscal Q1 ResultsShowingA Strong Growth Trajectory
26/08/2019
REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Biotricity  Inc.  (OTCQB :  BTCY ), a medical diagnostic and consumer healthcare technology company, today announced financial results for its first quarter ending [...]
Novo Nordisk A/S – Share repurchase programme
26/08/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 26 August 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Transactions under Novozymes’ stock buyback program
26/08/2019
Please read the full announcement in the attached PDF Attachment 2019_32_Stock_Buybackprogram_EN
Radient Technologies Inc. Announces Amendment to Loan Facility with Moskowitz Capital
26/08/2019
EDMONTON, Alberta, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ), a global innovator in the industrial scale extraction and downstream [...]
Financial calendar 2019/20
26/08/2019
Company annuncement No. 14/2019 Attachment No 14 Financial calendar 2019_2020
Unum Therapeutics to Present at Upcoming September Investor Conferences
26/08/2019
CAMBRIDGE, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, today announced that [...]
Zogenix Announces Acquisition of Modis Therapeutics, Inc.
26/08/2019
Advances Zogenix’s strategy to provide transformative therapies to patients and families living with serious rare diseases Adds MT1621, a proprietary, late-stage investigational medicine targeting Thymidine Kinase 2 [...]
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
26/08/2019
HOUSTON, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted [...]
Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
26/08/2019
– Completed initial public offering, raising $72.0 million in gross proceeds – – Initiated ReDUX4, a Phase 2b clinical trial of losmapimod in FSHD – – Initiated a Phase 2 open label clinical trial of losmapimod in FSHD [...]
Ivy Brain Tumor Center and Salarius Pharmaceuticals Launch Collaborative Partnership to Develop New Cancer Treatment for Glioblastoma
26/08/2019
Comprehensive pre-clinical study will test first-in-class investigational therapy Seclidemstat PHOENIX and HOUSTON, Aug. 26, 2019 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at the Barrow Neurological Institute and [...]
Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights
26/08/2019
Company also announces changes to U.S. Management Team JERUSALEM, Israel and HACKENSACK, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (“Brainsway” or the “Company”), a global leader [...]

Pages